Pharmaceutical Business review

FDA approves Cheetah Medical’s cardiac monitor

The Reliant monitor is powered by Cheetah’s unique, patented Bioreactance technology, which has been used effectively in over 1,000 patients in various clinical settings including hemodynamic monitoring, heart failure, perioperative care, hemodialysis and stress testing.

Laura Rector, general manager at Cheetah Medical, said: “We believe that with Reliant, healthcare professionals see a device that can deliver a new standard of care.